Suppr超能文献

苦瓜和β-葡聚糖组合物对 STZ 诱导的大鼠糖尿病及其并发症的协同作用。

Synergic effects of bitter melon and β-Glucan composition on STZ-induced rat diabetes and its complications.

机构信息

Glucan Corp. Research Institute, Marine Biotechnology Center, Busan 617-763, Korea.

出版信息

J Microbiol Biotechnol. 2012 Jan;22(1):147-55. doi: 10.4014/jmb.1106.06037.

Abstract

β-Glucan purified from oats (OG) and bitter melon, Momordica charantia Linn (MC), water extracts have shown favorable effects on diabetes and its complications. We investigated to find out the optimal composition showing hypoglycemic and antidiabetic complication effects in variable compositions (OG:MC = 1:1, 1:2, 1:4, 1:6, 1:8, 1:10, 2:1, 4:1, 6:1, 8:1, 10:1). Extracts were administered orally once a day for 28 days following 7 days post streptozotocin (STZ) dosing. Five rats per group (total 15 groups; Intact, STZ, OG, MC, and the variable composition groups) were selected according to the blood glucose and body weight at 6 days after STZ dosing. After 28 days of extracts dosing, the changes on the body weight, liver and kidney weight, blood glucose, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST) and alanine aminotransferase (ALT), low-density lipoprotein (LDL), and total-cholesterol levels were observed. As the result of STZ-induced diabetes, decreases of body weight, increases of the liver and kidney weights, blood glucose, BUN, creatinine, AST, ALT, LDL, and total-cholesterol levels in STZ control were detected compared with intact control. However, these changes of hyperglycemia, diabetic nephropathy, hepatopathy, and hyperlipemia were dramatically decreased in the OG and MC single-dosing group, and all composition groups. In addition, there were more favorable effects in all composition groups compared with the OG and MC single-dosing groups. Among variable compositions, the OG:MC 1:2 mixed group showed the most synergic effects in this study.

摘要

从燕麦(OG)和苦瓜(Momordica charantia Linn,MC)中提取的β-葡聚糖的水提取物已显示出对糖尿病及其并发症的有利影响。我们研究了不同组成(OG:MC = 1:1、1:2、1:4、1:6、1:8、1:10、2:1、4:1、6:1、8:1、10:1)的最佳组成,以显示出降血糖和抗糖尿病并发症的效果。提取物每天口服一次,在链脲佐菌素(STZ)给药后 7 天进行,共 28 天。根据 STZ 给药后 6 天的血糖和体重,每组选择 5 只大鼠(共 15 组;完整、STZ、OG、MC 和可变组成组)。在提取物给药 28 天后,观察体重、肝肾功能、血糖、血尿素氮(BUN)、肌酐、天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)、低密度脂蛋白(LDL)和总胆固醇水平的变化。由于 STZ 诱导的糖尿病,与完整对照组相比,STZ 对照组的体重、肝肾功能、血糖、BUN、肌酐、AST、ALT、LDL 和总胆固醇水平降低。然而,OG 和 MC 单剂量组以及所有组成组均显著降低了高血糖、糖尿病肾病、肝病和高脂血症的这些变化。此外,与 OG 和 MC 单剂量组相比,所有组成组都有更有利的效果。在可变组成中,OG:MC 1:2 混合组在本研究中显示出最强的协同作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验